388 related articles for article (PubMed ID: 25054270)
1. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
3. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer.
Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L
Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353
[TBL] [Abstract][Full Text] [Related]
4. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
[TBL] [Abstract][Full Text] [Related]
6. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
7. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1.
Chen R; Li D; Zheng M; Chen B; Wei T; Wang Y; Li M; Huang W; Tong Q; Wang Q; Zhu Y; Fang W; Guo L; Fang S
J Cell Mol Med; 2020 Feb; 24(3):2123-2134. PubMed ID: 31957179
[TBL] [Abstract][Full Text] [Related]
8. Identification of DJ-1 as a contributor to multidrug resistance in human small-cell lung cancer using proteomic analysis.
Gao H; Niu Y; Li M; Fang S; Guo L
Int J Exp Pathol; 2017 Apr; 98(2):67-74. PubMed ID: 28580701
[TBL] [Abstract][Full Text] [Related]
9. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
10. [Role of homeobox gene A5 in multidrug resistance of human small cell lung cancer cells].
Xiao F; Chen Z; Zeng X; Bai Y; Guo L; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1665-8. PubMed ID: 24273274
[TBL] [Abstract][Full Text] [Related]
11. Elevated fibroblast growth factor-inducible 14 expression promotes gastric cancer growth via nuclear factor-κB and is associated with poor patient outcome.
Kwon OH; Park SJ; Kang TW; Kim M; Kim JH; Noh SM; Song KS; Yoo HS; Wang Y; Pocalyko D; Paik SG; Kim YH; Kim SY; Kim YS
Cancer Lett; 2012 Jan; 314(1):73-81. PubMed ID: 21993017
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
13. TWEAK/Fn14 signaling mediates gastric cancer cell resistance to 5-fluorouracil via NF-κB activation.
Kwon OH; Kim JH; Kim SY; Kim YS
Int J Oncol; 2014 Feb; 44(2):583-90. PubMed ID: 24337061
[TBL] [Abstract][Full Text] [Related]
14. [Role of SALL4 in regulating multi-drug resistance of small cell lung cancer and its clinical significance].
Liu H; Bai Y; Wang W; Guo L
Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):604-8. PubMed ID: 25471501
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.
Li D; Zhang Y; Xie Y; Xiang J; Zhu Y; Yang J
Cancer Gene Ther; 2013 Apr; 20(4):251-9. PubMed ID: 23470565
[TBL] [Abstract][Full Text] [Related]
16. [Role and clinical significance of RLIP76 in regulation of multi-drug resistance of small cell lung cancer].
Haixia P; Yifeng B; Honglin H
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):266-71. PubMed ID: 26462890
[TBL] [Abstract][Full Text] [Related]
17. [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer
and its clinical significance].
Yang L; Hu H; Deng Y; Bai Y
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):769-77. PubMed ID: 25404266
[TBL] [Abstract][Full Text] [Related]
18. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
19. [Influence of interference of WIG-1 on the multi-drug resistance in small cell lung cancer].
Luo S; Bai Y; Lan H
Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):733-8. PubMed ID: 25567302
[TBL] [Abstract][Full Text] [Related]
20. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
